期刊文献+

GnRH及其受体表达与肝癌细胞增殖和分化的关系 被引量:3

Relationship of gonadotropin releasing hormone and its receptor expression with human hepatocarcinoma cell proliferation and differentiation
下载PDF
导出
摘要 探讨促性腺激素释放激素(GnRH)及其受体表达与肝癌病理学分级和肝癌细胞增殖的关系.方法:用常规组织学HE染色确定肝癌的病理学分级;用免疫组织化学SABC技术检测49例肝细胞性肝癌(HCC)中增殖细胞核抗原(PCNA),GnRH及其受体的表达.结果:GnRH及其受体均定位于肝癌细胞的胞膜和胞浆.Ⅰ级~Ⅱ级肝癌组织GnRH的阳性率为84.6%(20/23),显著高于Ⅲ级肝癌47.1%(8/17)的阳性率(P<0.05)和Ⅳ级肝癌11.1%(1/9)的阳性率(P<0.01).Ⅰ级~Ⅱ级肝癌组织GnRH受体的阳性率为91.1%(21/23),明显高于Ⅲ级肝癌41.2%(7/17)的阳性率(P<0.01)和Ⅳ级肝癌11.1%(1/9)的阳性率(P<0.01).GnRH阳性肝癌的PCNA标记指数(20.4±12.1)%低于GnRH阴性肝癌(39.1±25.3)%(P<0.05);GnRH受体阳性肝癌的PCNA标记指数(19.2±13.5)%亦明显低于GnRH受体阴性肝癌(40.5±29.1)%(P<0.01).结论:GnRH可能参与肝癌细胞的增殖和分化的调节. Aim:To explore the possible relationship of gonadotropin releasing hormone (GnRH) and its receptor(GnRHR) expression with hepatocarcinoma cell proliferation and differentiation. Methods: Proliferating cell nuclearantigen (PCNA),GnRH and its receptor were detected in 49hepatocellular carcinoma (HCC) by immunohistochemicalSABC technique. The pathological degree of HCC wasdemonstrated by hematoxilin and eosin (HE) staining. Results:GnRH and its receptor had the same distribution pattern in hepatocarcinoma cells. The positive signal was foundmainly on the surface and in the cytoplasm of hepatomacells. Edmondson's grade Ⅰ~Ⅱ HCC had a higher GnRHpositive rate (84. 6%; 20/23) than those of grade Ⅲ HCC(47. 1 %; 8/17) and grade Ⅳ HCC (11. 1 %;1/9),the differences were significant (P<0. 05 and P<0. 01 respectively).In grades Ⅰ~Ⅱ HCC GnRHR positive rate was 91. 1 % (21/23),which was higher than 41. 2% (7/17) in grade Ⅲ HCC(P<0.01) and 11.1 % (1/9) in grade Ⅳ HCC (P<0. 01 ).The PCNA labeling index was (20. 4±12. 1 ) % in GnRHpositive HCC and (39.1±25. 3) % in GnRH negative HCC,the difference was significant (P< 0.05 ); similarly, GnRHRpositive HCC also had a lower PCNA labeling index(19.2±13. 5 ) % than that of GnRHR negative HCC (40. 5±29. 1 ) %(P<0. 01 ). Conclusion: GnRH might be involved in theregulation of human hepatocarcinoma cell proliferation anddifferentiation.
出处 《第四军医大学学报》 1998年第4期381-384,共4页 Journal of the Fourth Military Medical University
基金 九五全军医药卫生科研基金!96M103
关键词 肝肿瘤 肝细胞癌 GNRH 受体 免疫组织化学 hepatocellular carcinoma gonadotropin releasing hormone receptor immunohistochemistry
  • 相关文献

参考文献2

  • 1池肇春,新编实用肝病学,1994年,394页
  • 2Yager J D,Prog Soc Exp Biol Med,1991年,198卷,2期,667页

同被引文献22

  • 1刘艳,陈文卫,李珏颖,张玉国,孙彬,胡伟,黄秀娟.SonoLiver时间强度曲线在肝脏局灶性占位病变超声造影中的应用价值[J].中华医学超声杂志(电子版),2011,8(5):1023-1032. 被引量:29
  • 2杨琼,魏文斌.超声造影及其在眼科的临床应用[J].国际眼科纵览,2007,31(3):145-148. 被引量:7
  • 3李增灿,侯鹏,陈频佳.序贯治疗中、晚期肝癌的临床研究[J].临床肝胆病杂志,1997,13(2):106-107. 被引量:1
  • 4朱平,张惠琴,冷南,吴振虎,贺宏德,陈志南.^(131)I抗人肝癌单抗片段交联物治疗原发性肝癌[J].第四军医大学学报,1997,18(3):293-294. 被引量:4
  • 5Hua X, Zhu LP, Li R, et al. Effects of diagnostic contrast- enhanced ultrasound on permeability of placental barrier: a primary study. Placenta, 2009,30 : 780 ?84.
  • 6Salvatore V, Borghi A,Piscaglia F. Contrast-enhanced ultrasound for liver imaging: recent advances. Curt Pharm Des, 2012, 18 2236-2252.
  • 7Bulte CS, Slikkerveer J, Meijer RI, et al. Contrast-enhanced ultrasound for myocardial perfusion imaging. Anesth Analg, 2012,114 : 938-945.
  • 8Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation, 1998,97 : 473-483.
  • 9Sidhu PS,Choi BI, Nielsen MB.The EFSUMB Guidelines on the Non-hepatic Clinical Applications of Contrast Enhanced Ultrasound (CEUS):a new dawn for the escalating use of this ubiquitous technique[J]. Ultraschall Med. 2012,33 ( 1 ) : 5-7.
  • 10Piscaglia F,Bolondi L,Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents- The safety of SonoVue in abdominal applications: retrospective analysis of 23188 investigations [ J ]. Ultrasound Med Biol,2006,32(9) : 1369-1375.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部